|Articles|September 23, 2016

Cryoport and Database Integrations Launch Solution

Cryoport has announced the integration of its Cryoportal logistics solution with Database Integration’s Integrated Cell Therapy Automated Network (iCAN) scheduling platform.

Cryoport has announced the integration of its Cryoportal logistics solution with Database Integration’s Integrated Cell Therapy Automated Network (iCAN) scheduling platform. The integration of these two platforms is designed to solve the challenges of manufacturing, distribution and global supply chain planning.

Read the full release here

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Cryoport and Database Integrations Launch Solution

Related Content

Beyond Patient Centricity: What Rare Disease Research Gets Right

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

Why Time Savings Is the Largest Driver of RBQM's Financial Value

Trending on Applied Clinical Trials Online

From Perspective to Action: Addressing the Real Cost Pressures in Clinical Trial Budgeting

Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal

Beyond Patient Centricity: What Rare Disease Research Gets Right

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files